Situation normale

Innogents
 SRL

2547 Lint
Since 24/10/2019
BE0736765280
Financial Health Indicator
8
Equity
€71.6K
Gross Operating Margin
€26.3K
+52% YoY
EBITDA
€25.7K
+54% YoY
Gain/Loss
€19.3K
+95% YoY

Innogents’s business network visualized

Explore our interactive spiderweb to visually navigate Innogents’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb Innogents
Innogents
  • MICHAEL GASTMANS
    2547 Lint
    Since 2019

Detailed insights into Innogents’s financial history

See financial trends including, equity, operating income, profit/loss and employees of Innogents. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020
Equity
71.6K
71.6K
61.7K
28.7K
Gross Operating Margin
26.3K
17.3K
46.9K
36.8K
Gain/Loss
19.3K
9.9K
33.0K
26.2K

Frequently asked questions about Innogents

  • What is the email adress of Innogents?

    You can contact Innogents at the email address info@innogents.com.
  • Where is Innogents located?

    Innogents’s headquarters is located in Schaapdries 42 , 2547 Lint.
  • Who are the directors of Innogents?

    Innogents’s directors include
    • MICHAEL GASTMANS
  • When was Innogents founded?

    Innogents was founded in 2019-10-24. Innogents has been active for 5 years.
  • What are Innogents’s NACEBEL codes?

    Innogents’s NACEBEL codes are
    • 70220 Conseil pour les affaires et autres conseils de gestion (2008)
    • 62020 Conseil informatique (2008)
    • 63990 Autres services d'information n.c.a. (2008)
    • 70210 Conseil en relations publiques et en communication (2008)
  • What is Innogents’s VAT number?

    Innogents’s VAT number is BE0736765280.
  • What is Innogents’s juridical form?

    Innogents’s juridical type is Société à responsabilité limitée (SRL).
  • How is the financial situation of Innogents?

    openthebox has estimated that Innogents’s financial health score to be 8/10.